CD265,familial expansile osteolysis,FEO,LOH18CR1,loss of heterozygosity, 18, chromosomal region 1,ODFR,OFE,OPTB7,osteoclast differentiation factor receptor,OSTS,Paget disease of bone 2,PDB2,RANK,receptor activator of NF-KB,receptor activator of nuclear factor-kappa B,TRANCE receptor,TRANCER,TRANCE-R,tumor necrosis factor receptor superfamily member 11A,tumor necrosis factor receptor superfamily, member 11a, NFKB activator.
Receptor for TNFSF11/RANKL/TRANCE/OPGL, essential for RANKL-mediated osteoclastogenesis. Involved in the regulation of interactions between T-cells and dendritic cells.
